Episodes 1-15 of 65
Tailored Treatment in Retinal Disease: Using Biomarkers to Guide Anti-VEGF Therapy
Eye on Ocular HealthTailored Treatment in Retinal Disease: Using Biomarkers to Guide Anti-VEGF Therapy
The Evolution of Retinal Vein Occlusion Treatment: From Laser to Anti-VEGF
Eye on Ocular HealthThe Evolution of Retinal Vein Occlusion Treatment: From Laser to Anti-VEGF
Strategies for Addressing Complications in Retinal Vein Occlusion
Eye on Ocular HealthStrategies for Addressing Complications in Retinal Vein Occlusion
Overcoming Barriers in Dry Eye Disease Care: Current and Emerging Options
Eye on Ocular HealthOvercoming Barriers in Dry Eye Disease Care: Current and Emerging Options
Evaluating Eyelid Wipes for Dry Eye Disease: Clinical Trial Insights
Eye on Ocular HealthEvaluating Eyelid Wipes for Dry Eye Disease: Clinical Trial Insights
- advertisement
Imaging and Proteomics: Differentiating Neuropathic Corneal Pain from Dry Eye
Eye on Ocular HealthImaging and Proteomics: Differentiating Neuropathic Corneal Pain from Dry Eye
Defining Chronic Ocular Surface Pain: Causes, Clues, and Complexity
Eye on Ocular HealthDefining Chronic Ocular Surface Pain: Causes, Clues, and Complexity
Personalizing Treatment for Chronic Ocular Surface Pain
Eye on Ocular HealthPersonalizing Treatment for Chronic Ocular Surface Pain
Targeting Inflammation in Dry Eye with ILYX-002: Early Clinical Trial Results
Eye on Ocular HealthTargeting Inflammation in Dry Eye with ILYX-002: Early Clinical Trial Results
Comparing Anti-VEGF Therapies: Real-World Insights on Efficacy, Safety, and Dosing
Eye on Ocular HealthComparing Anti-VEGF Therapies: Real-World Insights on Efficacy, Safety, and Dosing
Optimizing Anti-VEGF Sequencing: Strategies to Reduce Burden and Personalize Care
Eye on Ocular HealthOptimizing Anti-VEGF Sequencing: Strategies to Reduce Burden and Personalize Care
- advertisement
Decoding Variable Responses to Anti-VEGF Therapy in AMD and DME Care
Eye on Ocular HealthDecoding Variable Responses to Anti-VEGF Therapy in AMD and DME Care
Risk of RVO in Type 2 Diabetes: GLP-1 Receptor Agonists Versus DPP-4 Inhibitors
Eye on Ocular HealthRisk of RVO in Type 2 Diabetes: GLP-1 Receptor Agonists Versus DPP-4 Inhibitors
OCT Biomarkers as Predictors of Treatment Response in RVO-Related Macular Edema
Eye on Ocular HealthOCT Biomarkers as Predictors of Treatment Response in RVO-Related Macular Edema
